Skip to main content
SpringerLink
Log in

Chemotherapiefreies Regime

Rituximab und Lenalidomid zur Behandlung des follikulären Lymphoms

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Fowler NH et al. Lancet Oncol. 2014;15(12):1311–8

    Article  CAS  Google Scholar 

  2. Kimby E et al. Blood. 2014;124(21):799

    Google Scholar 

  3. Morschhauser F et al. N Engl J Med. 2018;379(10):934–47

    Article  CAS  Google Scholar 

  4. Attal M et al. N Engl J Med. 2010;366(19):1782–91

    Article  Google Scholar 

  5. McCarthy PL et al. N Engl J Med. 2012;366(19):1770–81.

    Article  CAS  Google Scholar 

Literatur

  • Morschhauser F et al. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma. N Engl J Med. 2018;379(10):934–47.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinisches Zentrum für Hämatologie und Onkologie, München MVZ GmbH, München, Deutschland

    Erhard Hiller

Authors
  1. Erhard Hiller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erhard Hiller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hiller, E. Rituximab und Lenalidomid zur Behandlung des follikulären Lymphoms. Info Onkol. 21, 10–11 (2018). https://doi.org/10.1007/s15004-018-6262-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-6262-6

Search

Navigation